$28.25
-0.20-0.7%
al cierre: Nov 17, 4:00 PM EST
$28.25
N/A
After hour: 4:00 PM EST
Parabilis Medicines (PBLS) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q3 | Nov 12, 2026 | $-0.36 | $-0.38 | 5.26 % |
| Q2 | Aug 13, 2026 | $-2.32 | $-0.23 | -908.7 % |
Quarterly Revenue (Billions)
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q3 | Nov 12, 2026 | $2.11M | $500.00K | 322.8 % |
| Q2 | Aug 13, 2026 | $148.00K | $16.67M | -99.1 % |
| Metric | Q3 '26 | Q2 '26 |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Estimate | $-0.38 | $-0.23 |
| Actual | $-0.36 | $-2.32 |
| Surprise | +5.26% | -908.7% |
| Revenue | ||
| Estimate | $500000 | $16.7M |
| Actual | $2.1M | $148000 |
| Surprise | +322.8% | -99.1% |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.43 | $-0.39 | $-0.38 | $-0.39 |
| Revenue | ||||
| Consensus | $1.1M | $1.5M | — | — |
